Anthropic has launched Claude Fable 5, its most capable publicly available AI model, excelling in complex tasks and benchmarks. Alongside i...

India has a structural advantage in quantum computing. Its size inherently creates challenging optimisation issues, offering a practical te...

Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...

For the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...

After the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...

If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

India and Italy are shaping an Indo-Mediterranean partnership focused on trade, AI, defence, clean energy and connectivity, with Narendra M...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

Amaravati, a new city in Andhra Pradesh, is becoming a hub for quantum computing. A technology park called Quantum Valley is attracting sci...

AI-driven drug discovery firm Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital will fuel the expansion of t...

Alphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by Thrive Capital. ...

Over the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...

Airbus landing on highway: The exercise was organised to assess the expressway’s potential as an alternative runway during times of war or ...

Whether you are a trader or an investor, there is one thing to watch carefully in the coming days: Earnings. The reason why this is importa...

A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...

Biocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They...

The official kickoff of the Q4 earnings season happens when a large IT company announces its results, although the quarter’s business updat...